| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |